Abstract:The number of mitochondria in the oocyte along with their functions (e.g., energy production, scavenger activity) decline with age progression. Such multifaceted functions support several processes during oocyte maturation, ranging from energy supply to synthesis of the steroid hormones. Hence, it is hardly surprising that their impairment has been reported in both physiological and premature ovarian aging, wherein they are crucial players in the apoptotic processes that arise in aged ovaries. In any form, ovarian aging implies the progressive damage of the mitochondrial structure and activities as regards to ovarian germ and somatic cells. The imbalance in the circulating hormones and peptides (e.g., gonadotropins, estrogens, AMH, activins, and inhibins), active along the pituitary-ovarian axis, represents the biochemical sign of ovarian aging. Despite the progress accomplished in determining the key role of the mitochondria in preserving ovarian follicular number and health, their modulation by the hormonal signalling pathways involved in ovarian aging has been poorly and randomly explored. Yet characterizing this mechanism is pivotal to molecularly define the implication of mitochondrial dysfunction in physiological and premature ovarian aging, respectively. However, it is fairly difficult considering that the pathways associated with ovarian aging might affect mitochondria directly or by altering the activity, stability and localization of proteins controlling mitochondrial dynamics and functions, either unbalancing other cellular mediators, released by the mitochondria, such as non-coding RNAs (ncRNAs). We will focus on the mitochondrial ncRNAs (i.e., mitomiRs and mtlncRNAs), that retranslocate from the mitochondria to the nucleus, as active players in aging and describe their role in the nuclear-mitochondrial crosstalk and its modulation by the pituitary-ovarian hormone dependent pathways. In this review, we will illustrate mitochondria as targets of the signaling pathways dependent on hormones and peptides active along the pituitary/ovarian axis and as transducers, with a particular focus on the molecules retrieved in the mitochondria, mainly ncRNAs. Given their regulatory function in cellular activities we propose them as potential diagnostic markers and/or therapeutic targets.

Oocyte Health and Quality: Implication of Mitochondria-related Organelle Interactions

Mitochondrial Functions on Oocytes and Preimplantation Embryos

Mitochondria: Their relevance during oocyte ageing

Mitochondria: the panacea to improve oocyte quality?

Advances in role of mitochondria in maturation of oocyte

Mechanisms of mitochondrial dysfunction in ovarian aging and potential interventions

Understanding oocyte ageing: can we influence the process as clinicians?

Oocyte mitochondria—key regulators of oocyte function and potential therapeutic targets for improving fertility

Ovarian aging: energy metabolism of oocytes

Mitochondria in Ovarian Aging and Reproductive Longevity

Targeting Mitochondria for Ovarian Aging: New Insights into Mechanisms and Therapeutic Potential

Ovarian aging: mechanisms and intervention strategies

The Role of Mitochondria in Oocyte Maturation

Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence

Mitochondrial DNA Damage and Its Repair Mechanisms in Aging Oocytes

Oocyte Mitochondiral Aging——Bottleneck of Assisted Reproductive Technology(ART)

Mitochondrial dysfunction and endoplasmic reticulum stress involved in oocyte aging: an analysis using single-cell RNA-sequencing of mouse oocytes

Role of Granulosa Cells in the Aging Ovarian Landscape: A Focus on Mitochondrial and Metabolic Function

Research progress on mitochondrial damage and repairing in oocytes: a review

Ovarian Aging: Role of Pituitary-Ovarian Axis Hormones and ncRNAs in Regulating Ovarian Mitochondrial Activity

Mitochondrial dynamics and interorganellar communication in the development and dysmorphism of mammalian oocytes